---
title: "Auranofin - Rheumatoid arthritis"
sidebar: mydoc_sidebar
permalink: auranofinrheumatoidarthritis.html
toc: false 
---

{% include image.html file="auranofinrheumatoidarthritis.png" alt="auranofinrheumatoidarthritis" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D001310 | Auranofin | Drug |
| UniProt:O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Protein |
| CL:0000235 | Macrophage | Cell |
| GO:0006955 | Immune response | BiologicalProcess |
| GO:0006954 | Inflammation | BiologicalProcess |
| MESH:D001172 | Rheumatoid arthritis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Auranofin | DECREASES ACTIVITY OF | Inhibitor Of Nuclear Factor Kappa-B Kinase Subunit Beta |
| Auranofin | NEGATIVELY REGULATES | Macrophage |
| Inhibitor Of Nuclear Factor Kappa-B Kinase Subunit Beta | POSITIVELY REGULATES | Immune Response |
| Macrophage | PARTICIPATES IN | Immune Response |
| Immune Response | POSITIVELY CORRELATED WITH | Inflammation |
| Inflammation | CAUSES | Rheumatoid Arthritis |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00995#mechanism-of-action](https://go.drugbank.com/drugs/DB00995#mechanism-of-action){:target="_blank"}